Anthropic ANT IPO: Claude Stock Price and Key Facts 2026

Anthropic, the AI company behind Claude, went public on the Nasdaq under the ticker ANT on November 19, 2026, with an IPO price of $83 per share. The stock opened at $111.50 and closed at $97.17, giving the company a market valuation of about $1.27 trillion. Anthropic reported $80 billion in annualized revenue by October 2026 but also an $80.7 billion loss in the first half of 2026.

Original reporting
Published Nov 21, 2026, 10:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 22, 2026, 1:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Anthropic ANT IPO: Claude Stock Price and Key Facts 2026 — source image
Decision brief

The 30-second read

$ANTBullishMed
01

Why it matters

The trading-relevant takeaway is the IPO offer-to-close repricing and the intraday drawdown from the peak, which together signal both demand and valuation risk.

02

Market read

Provides concrete IPO pricing and first-session trading levels for ANT, useful for understanding immediate post-listing sentiment and volatility.

03

What to watch

The article emphasizes losses and planned data-center spend, but does not quantify near-term funding runway, margin trajectory, or customer contract terms that could drive subsequent repricing.

Relevance 4/10Novelty 4/10Timing: post-IPO debut, after-hours/next-session positioning following Nov. 19, 2026 close

Background

Anthropic, the Claude AI developer, confidentially filed an S-1 in June 2026 and then listed on Nasdaq as ANT in November 2026.

Company-level read

Ticker impact

$ANTBullishMedium confidence
Context

Article states Anthropic listed on Nasdaq under ticker ANT on Nov. 19, 2026, with $111.50 open and $97.17 close after $83 offer.

Expected impact

Likely near-term volatility as the market digests the IPO valuation and early trading range versus the $83 offer price.

Evidence & confidence

The piece provides concrete debut pricing (open, intraday low, close) and offer terms, which are directly relevant to how traders price supply, demand, and valuation risk immediately after listing.

Market effects

Highlights enterprise AI valuation tension (high revenue growth vs heavy losses and data-center spend), which can influence sentiment toward other AI infrastructure and platform names.

US Nasdaq listing and first-day trading can affect broader US growth/AI risk appetite, but the article is single-issuer focused.

Limited direct global spillover beyond reinforcing global investor appetite for large-scale AI IPOs and enterprise AI monetization narratives.

Counterpoint

Strong first-day pricing can reverse if lock-up expectations, valuation skepticism, or continued cash burn dominate once initial hype fades.

Key entities

  • Anthropic

    Nasdaq-listed AI company behind Claude, subject of the IPO and debut trading details in the article.

  • Nasdaq

    Exchange where ANT began trading on Nov. 19, 2026.

Related articles

$TSMMed

Export boom sends Q3 surplus soaring

Taiwan's Q3 current account surplus hit US$68.79B, driven by record exports of US$225.8B, largely due to AI-related demand. TSMC acquired a 0.03% stake in AI firm Anthropic for US$500M. Lam Research and SPIL announced expansions to support AI infrastructure. TSMC tightened restrictions on Chinese chip designers, limiting access to advanced tech.

$ANTMed

Anthropic Stock $88.91: 5 Analyst Targets Average $134

Anthropic's stock closed at $88.91 on Friday, down 8.5% from its debut. Analysts set targets averaging $134, with Melius Research highest at $155. Seaport Research rated it Neutral. The stock is 7.1% above its IPO price. Underwriters' research is expected after a 10-day quiet period.

$ANTHighAI 8/10

Anthropic rings the Nasdaq bell and then solves Riemann Hypothesis, what next now?

Anthropic (ANT) debuted on Nasdaq with a $1.5T market cap, briefly surpassing $2T before a selloff. The company aims to focus on institutional AI applications, particularly in medicine, and claims to have solved the Riemann Hypothesis. However, it faces challenges in justifying its valuation, with projected 2026 revenue of $45B falling short of the $600B needed for 20% returns on $1T AI investment. Sarvam, an Indian AI company, pivoted to offering inference services, sparking debate.

$ANTHighAI 8/10

How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

Anthropic (ANT) priced its IPO at $83.00 per share, raising $81.3 billion, and began trading on Nasdaq at $111.50. Leverage Shares by Themes plans to launch ANUU, a 2X leveraged ETF tracking ANT, on November 23, 2026. The ETF is designed for active traders seeking daily 2X exposure to Anthropic's stock performance, with an expense ratio of 0.75%.

$ANTMed

[IT Times Weekly] Anthropic’s $93.5B Nasdaq Debut and Factory Humanoids Signal AI’s Industrial Era

Anthropic debuted on Nasdaq at $83/share, raising $93.5B (total $119.5B incl. private placement). Microsoft's AI security initiative flagged 9,791 vulnerabilities. Boston Dynamics' humanoid Atlas to trial in semiconductor fabs. Hyundai launched Avante with AI infotainment. Tether invested in SCRYPT for institutional crypto services. POSCO secured 3-year lithium supply deal with CATL.